Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2023 INTERIM RESULTS (H SHARES) 2023-08-23 20:34
Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit 2023-08-23 20:06
Food Science, which developed the world's first hangover drink with the protein of blowfish, launches the fruit-flavored carbonated drink 'VTalk Ade' 2023-08-23 20:00
Innovent Announces 2023 Interim Results and Business Updates 2023-08-23 19:38
Dizal's Sunvozertinib Approved by China NMPA with Potential for Best-in-class Therapy in NSCLC with EGFR Exon20ins Mutations 2023-08-23 19:21
Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US 2023-08-23 18:07
Waterdrop Inc. to Report Second Quarter 2023 Financial Results on September 7, 2023 2023-08-23 18:06
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company 2023-08-23 17:40
USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023 2023-08-23 17:06
Leading by Inspiration: KPJ Tawakkal KL Specialist Hospital Triumphs with Asia Pacific Enterprise Award for its Exceptional Brand 2023-08-23 15:18
Green Living Starts Here: A Look at Practical Steps to Sustainability at Home 2023-08-23 14:40
Waterdrop Insurance Marketplace Unveils Blue Ocean LifeTime Health Insurance, Paving the Way for Affordable Premium Healthcare Insurance Solutions 2023-08-23 12:12
ImmVira Appoints Howard L. Kaufman, M.D. as Consulting Medical Advisor 2023-08-23 10:51
MGI Partners with NGeneBio to Advance Precision Medicine 2023-08-23 09:00
Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis 2023-08-23 08:00
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results 2023-08-22 22:00
Paradigm Therapeutics Acquires Late Stage "Breakthrough Therapy" Designated Therapy for Treatment of All Subtypes of Epidermolysis Bullosa (EB) 2023-08-22 21:13
Asieris Pharmaceuticals Unveils 2023 Semi-Annual Report, Demonstrating Initial Success of Specialty Pharma Strategy and Multi-Product Synergistic Commercialization 2023-08-22 20:58
Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development 2023-08-22 20:00
CARsgen Announced 2023 Interim Results 2023-08-22 19:30
1 117 118 119 120 121 1508